2020
DOI: 10.2147/opth.s259642
|View full text |Cite
|
Sign up to set email alerts
|

<p>Evaluation of Vision-Related Quality of Life after Autologous Internal Limiting–Membrane Transplantation for Refractory Macular Holes</p>

Abstract: Purpose To evaluate the vision-related quality of life of vitrectomy combined with autologous internal limiting membrane (ILM) transplantation for refractory macular holes (MHs). Methods There were 40 eyes with refractory MHs included, and all eyes received 23 G vitrectomy and ILM peeling with autologous ILM transplantation. Preoperative and postoperative basic conditions were recorded. The Chinese version of the vision-related quality-of-life scale was used to evaluate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…This treatment provides long-term good anatomical and functional results [ 52 ] 20 Yuan et al, 2020 (PMID:32801616) 40 China Mean age 55–58 RMH 85.9% Autologous ILM transplantation BCVA improved from 1.52 ± 0.29 to 1.09 ± 0.33 at 3 months. The VA of patients improved significantly improving their vision-related QoL [ 53 ] 21 Zhang et al, 2019 (PMID:31823798) 18 China Mean age 63.67 Idiopathic FTMH 82.6% ILM insertion BCVA improved at 3rd and 6th months in the NGF group, and in the insertion group after 6 months (p = 0.0081, 0.0276, and 0.0255, respectively, compared to baseline). The NGF group exhibited better recovery than the insertion group at 3rd month follow-up ( p = 0.0301).…”
Section: Resultsmentioning
confidence: 99%
“…This treatment provides long-term good anatomical and functional results [ 52 ] 20 Yuan et al, 2020 (PMID:32801616) 40 China Mean age 55–58 RMH 85.9% Autologous ILM transplantation BCVA improved from 1.52 ± 0.29 to 1.09 ± 0.33 at 3 months. The VA of patients improved significantly improving their vision-related QoL [ 53 ] 21 Zhang et al, 2019 (PMID:31823798) 18 China Mean age 63.67 Idiopathic FTMH 82.6% ILM insertion BCVA improved at 3rd and 6th months in the NGF group, and in the insertion group after 6 months (p = 0.0081, 0.0276, and 0.0255, respectively, compared to baseline). The NGF group exhibited better recovery than the insertion group at 3rd month follow-up ( p = 0.0301).…”
Section: Resultsmentioning
confidence: 99%
“…De Novelli and colleagues [ 17 ] obtained similar results in another small series of 10 eyes. Yuan et al [ 18 ] reported that quality of life measures also improved following MH closure using the AT-ILM technique.…”
Section: Discussionmentioning
confidence: 99%